RUTH PINTER: Open Payments
NPI 1417116732 · NORTH HOLLYWOOD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,239 in 73 payments from 7 companies in 2025. Trend: 2023 $732 · 2024 $731 · 2025 $1,239
Food & beverage: $1,239
| Company | Payments | Amount |
|---|---|---|
| Forte Bio-Pharma LLC | 43 | $667 |
| Novartis Pharmaceuticals Corporation | 13 | $243 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 7 | $147 |
| Collegium Pharmaceutical, Inc. | 5 | $84 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $44 |
| Virtus Pharmaceuticals LLC | 2 | $37 |
| PFIZER INC. | 1 | $17 |
Products named: PROLATE, COSENTYX, RELISTOR, Belbuca, JOURNAVX, LEVORPHANOL TARTRATE, TANLOR, NURTEC ODT.
Industry payments across CA — which companies pay providers there.
